Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Indaptus Therapeutics, Inc. has filed 325 SEC EDGAR filings since 20 Apr 2021

SEC filing history

Showing 51-70 of 70 matching filings.

Per page
25
Current page
3
8-K/A File 001-40652

8-K/A filing

Filing date
16 Aug 2021
Reporting date
12 Aug 2021
Next action
Verify source filing
8-K File 333-255389

8-K filing

Filing date
16 Jul 2021
Reporting date
13 Jul 2021
Next action
Verify source filing
8-K File 333-255389

8-K filing

Filing date
22 Jun 2021
Reporting date
21 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .